Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker OLMA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 12,500 | $146.4K | — | Jul 24, 2026 | Form 4 ↗ 3 days later · 25,000 shares | Form 144 ↗ |
| Jul 23, 2026 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 12,500 | $144.7K | — | Jul 23, 2026 | Form 4 ↗ 4 days later · 25,000 shares | Form 144 ↗ |
| Mar 16, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 4,166 | $69.2K | — | Mar 16, 2026 | — | Form 144 ↗ |
| Mar 16, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 100,000 | $1.6M | — | Mar 16, 2026 | — | Form 144 ↗ |
| Mar 11, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 50,000 | $796.8K | — | Mar 11, 2026 | — | Form 144 ↗ |
| Mar 10, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 53,206 | $904.6K | — | Mar 10, 2026 | — | Form 144 ↗ |
| Mar 9, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 241,999 | $3.3M | — | Mar 9, 2026 | — | Form 144 ↗ |
| Mar 4, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 20,000 | $488.7K | — | Mar 4, 2026 | — | Form 144 ↗ |
| Mar 4, 2026 | Mitchell Shawnte Officer | OLMA Olema Oncology, Inc. | 25,000 | $598.5K | — | Mar 4, 2026 | Form 4 ↗ 1 day later · 40,000 shares | Form 144 ↗ |
| Mar 3, 2026 | Mitchell Shawnte Officer | OLMA Olema Oncology, Inc. | 15,000 | $345.2K | — | Mar 3, 2026 | Form 4 ↗ 2 days later · 40,000 shares | Form 144 ↗ |
| Feb 27, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 6,521 | $163.0K | — | Feb 27, 2026 | — | Form 144 ↗ |
| Feb 24, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 20,000 | $500.0K | — | Feb 24, 2026 | — | Form 144 ↗ |
| Feb 23, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 10,000 | $243.0K | — | Feb 23, 2026 | — | Form 144 ↗ |
| Feb 23, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 20,000 | $480.0K | — | Feb 23, 2026 | — | Form 144 ↗ |
| Feb 12, 2026 | Shane William Charles Kovacs Former Officer | OLMA Olema Oncology, Inc. | 10,000 | $238.5K | — | Feb 12, 2026 | — | Form 144 ↗ |
| Jan 20, 2026 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 10,000 | $268.8K | — | Jan 20, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jan 15, 2026 | Shane William Charles Kovacs Officer | OLMA Olema Oncology, Inc. | 100,000 | $2.9M | — | Jan 15, 2026 | Form 4 ↗ same day · 103,822 shares | Form 144 ↗ |
| Jan 14, 2026 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 3,489 | $101.6K | — | Jan 14, 2026 | Form 4 ↗ 2 days later · 3,489 shares | Form 144 ↗ |
| Jan 14, 2026 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 50,000 | $1.4M | — | Jan 14, 2026 | Form 4 ↗ same day · 110,000 shares | Form 144 ↗ |
| Jan 13, 2026 | Shane William Charles Kovacs Officer | OLMA Olema Oncology, Inc. | 3,822 | $107.1K | — | Jan 13, 2026 | Form 4 ↗ 2 days later · 103,822 shares | Form 144 ↗ |
| Jan 13, 2026 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 50,000 | $1.4M | — | Jan 13, 2026 | Form 4 ↗ 1 day later · 110,000 shares | Form 144 ↗ |
| Jan 12, 2026 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 10,000 | $283.4K | — | Jan 12, 2026 | Form 4 ↗ 2 days later · 110,000 shares | Form 144 ↗ |
| Dec 23, 2025 | Zojwalla Naseem Officer | OLMA Olema Oncology, Inc. | 99,509 | $2.8M | — | Dec 23, 2025 | Form 4 ↗ same day · 199,509 shares | Form 144 ↗ |
| Dec 22, 2025 | Harmon Cyrus Officer | OLMA Olema Oncology, Inc. | 2,881 | $82.2K | — | Dec 22, 2025 | Form 4 ↗ 7 days later · 2,881 shares | Form 144 ↗ |
| Dec 22, 2025 | Zojwalla Naseem Officer | OLMA Olema Oncology, Inc. | 100,000 | $2.8M | — | Dec 22, 2025 | Form 4 ↗ 1 day later · 269,509 shares | Form 144 ↗ |
| Dec 19, 2025 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 51,000 | $1.6M | — | Dec 19, 2025 | Form 4 ↗ 4 days later · 51,000 shares | Form 144 ↗ |
| Dec 19, 2025 | Zojwalla Naseem Officer | OLMA Olema Oncology, Inc. | 70,000 | $2.0M | — | Dec 19, 2025 | Form 4 ↗ 4 days later · 269,509 shares | Form 144 ↗ |
| Dec 19, 2025 | Ian T. Clark Director | OLMA Olema Oncology, Inc. | 264,800 | $7.9M | — | Dec 19, 2025 | Form 4 ↗ 4 days later · 264,800 shares | Form 144 ↗ |
| Sep 18, 2025 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 13,086 | $109.0K | — | Sep 18, 2025 | Form 4 ↗ same day · 25,000 shares | Form 144 ↗ |
| Sep 16, 2025 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 11,914 | $95.8K | — | Sep 16, 2025 | Form 4 ↗ 2 days later · 25,000 shares | Form 144 ↗ |
| Dec 13, 2024 | Logos Opportunities Fund I LP Affiliate | OLMA Olema Oncology, Inc. | 700,761 | $4.7M | — | Dec 13, 2024 | — | Form 144 ↗ |
| Dec 11, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 8,137 | $70.6K | — | Dec 11, 2024 | Form 4 ↗ same day · 16,393 shares | Form 144 ↗ |
| Dec 11, 2024 | Shane William Charles Kovacs Officer | OLMA Olema Oncology, Inc. | 18,356 | $159.3K | — | Dec 11, 2024 | Form 4 ↗ same day · 35,159 shares | Form 144 ↗ |
| Dec 11, 2024 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 13,614 | $118.2K | — | Dec 11, 2024 | Form 4 ↗ same day · 26,066 shares | Form 144 ↗ |
| Dec 11, 2024 | Zojwalla Naseem Officer | OLMA Olema Oncology, Inc. | 14,522 | $126.1K | — | Dec 11, 2024 | Form 4 ↗ same day · 27,805 shares | Form 144 ↗ |
| Dec 11, 2024 | Sean Bohen Officer, Director | OLMA Olema Oncology, Inc. | 57,174 | $496.3K | — | Dec 11, 2024 | Form 4 ↗ same day · 109,502 shares | Form 144 ↗ |
| Dec 10, 2024 | Sean Bohen Officer, Director | OLMA Olema Oncology, Inc. | 52,328 | $490.2K | — | Dec 10, 2024 | Form 4 ↗ 1 day later · 109,502 shares | Form 144 ↗ |
| Dec 10, 2024 | David C. Myles Officer | OLMA Olema Oncology, Inc. | 12,452 | $116.7K | — | Dec 10, 2024 | Form 4 ↗ 1 day later · 26,066 shares | Form 144 ↗ |
| Dec 10, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 8,256 | $77.4K | — | Dec 10, 2024 | Form 4 ↗ 1 day later · 16,393 shares | Form 144 ↗ |
| Dec 10, 2024 | Shane William Charles Kovacs Officer | OLMA Olema Oncology, Inc. | 16,803 | $157.4K | — | Dec 10, 2024 | Form 4 ↗ 1 day later · 35,159 shares | Form 144 ↗ |
| Dec 10, 2024 | Zojwalla Naseem Officer | OLMA Olema Oncology, Inc. | 13,283 | $124.5K | — | Dec 10, 2024 | Form 4 ↗ 1 day later · 27,805 shares | Form 144 ↗ |
| Jul 30, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 934 | $14.5K | 10b5-1 | Jul 30, 2024 | — | Form 144 ↗ |
| Jul 29, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 4,066 | $63.4K | 10b5-1 | Jul 29, 2024 | — | Form 144 ↗ |
| Jul 11, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 5,000 | $61.3K | 10b5-1 | Jul 11, 2024 | — | Form 144 ↗ |
| Jun 28, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 20,000 | $215.4K | 10b5-1 | Jun 28, 2024 | — | Form 144 ↗ |
| Jun 6, 2024 | Logos Opportunities Fund II LP Director | OLMA Olema Oncology, Inc. | 475,000 | $6.6M | — | Jun 4, 2024 | — | Form 144 ↗ |
| Jun 6, 2024 | Logos Opportunities Fund I LP Director | OLMA Olema Oncology, Inc. | 700,000 | $9.8M | — | Jun 4, 2024 | — | Form 144 ↗ |
| Jun 4, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 5,000 | $61.6K | 10b5-1 | Jun 4, 2024 | — | Form 144 ↗ |
| Jun 3, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 5,000 | $54.7K | 10b5-1 | Jun 3, 2024 | — | Form 144 ↗ |
| May 31, 2024 | Harmon Cyrus Director | OLMA Olema Oncology, Inc. | 15,000 | $141.1K | 10b5-1 | May 31, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances